Smith Ross C, Southwell-Keely James, Chesher Douglas
Sydney University Department of Surgery, Royal North Shore Hospital, Sydney New South Wales, Australia.
ANZ J Surg. 2005 Jun;75(6):399-404. doi: 10.1111/j.1445-2197.2005.03391.x.
Serum pancreatic lipase may improve the diagnosis of pancreatitis compared to serum amylase. Both enzymes have been measured simultaneously at our hospital allowing for a comparison of their diagnostic accuracy.
Seventeen thousand five hundred and thirty-one measurements of either serum amylase and or serum pancreatic lipase were made on 10 931 patients treated at a metropolitan teaching hospital between January 2001 and May 2003. Of these, 8937 were initially treated in the Emergency Department. These results were collected in a database, which was linked by the patients' medical record number to the radiology and medical records. Patients with either an elevated lipase value or a discharge diagnosis of acute pancreatitis had their radiological diagnosis reviewed along with their biochemistry and histology record. The diagnosis of acute pancreatitis was made if there was radiological evidence of peripancreatic inflammation.
One thousand eight hundred and twenty-five patients had either elevated serum amylase and or serum pancreatic lipase. The medical records coded for pancreatitis in a further 55 whose enzymes were not elevated. Three hundred and twenty of these had radiological evidence of acute pancreatitis. Receiver operator characteristic analysis of the initial sample from patients received in the Emergency Department showed improved diagnostic accuracy for serum pancreatic lipase (area under the curve (AUC) 0.948) compared with serum amylase (AUC, 0.906, P < 0.05). A clinically useful cut-off point would be at the diagnostic threshold; 208 U/L (normal <190 U/L) for serum pancreatic lipase and 114 U/L (normal 27-100 U/L) for serum amylase where the sensitivity was 90.3 cf., 76.8% and the specificity was 93 cf., 92.6%. 18.8% of the acute pancreatitis patients did not have elevated serum amylase while only 2.9% did not have elevated serum pancreatic lipase on the first emergency department measurement.
It is concluded that serum pancreatic lipase is a more accurate biomarker of acute pancreatitis than serum amylase.
与血清淀粉酶相比,血清胰脂肪酶可能会改善胰腺炎的诊断。在我们医院,这两种酶都同时进行了检测,以便比较它们的诊断准确性。
2001年1月至2003年5月期间,对一家大都市教学医院收治的10931例患者进行了17531次血清淀粉酶和/或血清胰脂肪酶检测。其中,8937例最初在急诊科接受治疗。这些结果被收集到一个数据库中,该数据库通过患者的病历号与放射学和医疗记录相链接。胰脂肪酶值升高或出院诊断为急性胰腺炎的患者,其放射学诊断以及生化和组织学记录都进行了复查。如果有胰腺周围炎症的放射学证据,则诊断为急性胰腺炎。
1825例患者血清淀粉酶和/或血清胰脂肪酶升高。另有55例酶未升高的患者病历被编码为胰腺炎。其中320例有急性胰腺炎的放射学证据。对急诊科收治患者的初始样本进行的受试者操作特征分析显示,与血清淀粉酶(曲线下面积[AUC]0.906)相比,血清胰脂肪酶的诊断准确性有所提高(AUC为0.948,P<0.05)。临床有用的截断点将在诊断阈值处;血清胰脂肪酶为208 U/L(正常<190 U/L),血清淀粉酶为114 U/L(正常27 - 100 U/L),此时敏感性分别为90.3%和76.8%,特异性分别为93%和92.6%。在首次急诊科检测时,18.8%的急性胰腺炎患者血清淀粉酶未升高,而只有2.9%的患者血清胰脂肪酶未升高。
得出结论,血清胰脂肪酶是比血清淀粉酶更准确的急性胰腺炎生物标志物。